(Q40178522)

18 September 2017

Interaction of the B95-8 and P3HR-1 substrains of epstein-barr virus (EBV) with peripheral human lymphocytes (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

12 January 2023

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A212371

12 January 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

12 January 2023

2

T. Bakács

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A212371

12 January 2023

author name string

M. Steinitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A212371

12 January 2023

G. Klein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A212371

12 January 2023

language of work or name

English

0 references

publication date

1 September 1978

1 reference

18 September 2017

15 September 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=212371

full work available at URL

12 January 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910220306

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910220306

12 January 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

International Journal of Cancer

12 January 2023

published in

1 reference

18 September 2017

22

1 reference

18 September 2017

251-257

1 reference

18 September 2017

3

1 reference

Release of infectious Epstein-Barr virus by transformed marmoset leukocytes

18 September 2017

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1073/PNAS.70.1.190

Concentration of Epstein-Barr virus from cell culture fluids with polyethylene glycol

1

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Induction of epstein-barr virus-associated early antigen in different lymphoid cell lines with ultraviolet-irradiated P3HR-1 virus

12 January 2023

3

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Induction of ebna precedes the first cellular S-phase after ebv-infection of human lymphocytes

12 January 2023

4

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood

12 January 2023

5

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Lymphocyte stimulation by protein A ofStaphylococcus aureus

12 January 2023

6

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains

12 January 2023

7

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

In vitro stimulation of human lymphocytes by Epstein-Barr virus

12 January 2023

8

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Appearance of Epstein-Barr virus-associated antigens in infected Raji cells

12 January 2023

9

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis

12 January 2023

10

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures.

12 January 2023

11

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes

12 January 2023

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes

12 January 2023

13

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

A quantitative analysis of the susceptibility of human leukocytes to transformation by epstein-barr virus

12 January 2023

14

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus

12 January 2023

15

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection

12 January 2023

16

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of ebv-negative lymphoma lines and theirin vitro EBV-converted sublines

12 January 2023

17

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference

12 January 2023

21

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Classification and biological nature of established human hematopoietic cell lines

12 January 2023

22

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: size, structure, and relatedness

12 January 2023

23

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

12 January 2023

24

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

A practical and quantitative microtest for determination of neutralizing antibodies against Epstein-Barr virus

12 January 2023

27

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Cell-killing by Epstein-barr virus: Analysis by colony inhibition procedure

12 January 2023

29

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Inhibition of DNA Metabolism in Human B Lymphocytes by a Substrain of Epstein-Barr Virus (P3HR-1): A Method for Virus Quantitation

12 January 2023

30

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Nucleic acid renaturation and restriction endonuclease cleavage analyses show that the DNAs of a transforming and a nontransforming strain of Epstein-Barr virus share approximately 90% of their nucleotide sequences

12 January 2023

31

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Relationships between complement activation, complement binding, and EBV absorption by human hematopoietic cell lines

12 January 2023

32

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations

12 January 2023

33

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220306

12 January 2023

Identifiers

1 reference

18 September 2017

1 reference